Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
ptgx
/
Protagonist Therapeutics Inc
PTGX
Add to Watchlist
136.640
USD
-2.000
-1.44%
Close 07-31 16:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
8.79B
Market Cap
Loss
P/E TTM
Protagonist Therapeutics Inc
136.640
-2.000
-1.44%
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
12.94%
Farallon Capital Management, L.L.C.
9.55%
UBS Financial Services, Inc.
7.88%
RTW Investments L.P.
7.87%
Vanguard Portfolio Management, LLC
5.49%
Other
56.26%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
12.94%
Farallon Capital Management, L.L.C.
9.55%
UBS Financial Services, Inc.
7.88%
RTW Investments L.P.
7.87%
Vanguard Portfolio Management, LLC
5.49%
Other
56.26%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
41.53%
Investment Advisor
41.38%
Hedge Fund
19.80%
Venture Capital
3.81%
Research Firm
3.71%
Private Equity
2.23%
Pension Fund
1.88%
Individual Investor
0.72%
Bank and Trust
0.53%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
642
76.23M
118.60%
-3.23M
2025Q4
592
74.88M
119.78%
-4.87M
2025Q3
551
71.95M
115.09%
-3.63M
2025Q2
533
68.00M
109.30%
-9.94M
2025Q1
541
67.25M
108.51%
-8.96M
2024Q4
503
65.58M
106.87%
-12.21M
2024Q3
480
64.24M
108.98%
-11.36M
2024Q2
419
61.14M
104.21%
-15.61M
2024Q1
412
61.98M
106.36%
-12.46M
2023Q4
402
59.53M
103.21%
-16.02M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
8.32M
13.04%
+299.82K
+3.74%
Dec 31, 2025
Farallon Capital Management, L.L.C.
6.14M
9.63%
-52.00K
-0.84%
Dec 31, 2025
UBS Financial Services, Inc.
2.77M
4.33%
+872.73K
+46.12%
Dec 31, 2025
RTW Investments L.P.
5.06M
7.93%
-697.22K
-12.11%
Dec 31, 2025
Wellington Management Company, LLP
3.17M
4.97%
+1.26M
+66.18%
Dec 31, 2025
State Street Investment Management (US)
3.20M
5.01%
+33.93K
+1.07%
Dec 31, 2025
Janus Henderson Investors
2.65M
4.15%
+1.55M
+140.73%
Dec 31, 2025
Johnson & Johnson Innovation-JJDC, Inc.
2.45M
3.84%
--
--
Dec 31, 2025
Geode Capital Management, L.L.C.
1.45M
2.28%
+36.28K
+2.56%
Dec 31, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Invesco S&P SmallCap Health Care ETF
2.82%
Invesco S&P SmallCap 600 Pure Growth ETF
2.71%
Invesco Dorsey Wright Healthcare Momentum ETF
2.33%
ALPS Medical Breakthroughs ETF
1.99%
ETC 6 Meridian Small Cap Equity ETF
1.56%
State Street SPDR S&P Biotech ETF
1.44%
Cambria Value and Momentum ETF
1.16%
Invesco S&P SmallCap Momentum ETF
1%
Virtus LifeSci Biotech Clinical Trials ETF
0.94%
Direxion Daily S&P Biotech Bull 3X Shares
0.88%
View more
Invesco S&P SmallCap Health Care ETF
Proportion
2.82%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion
2.71%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion
2.33%
ALPS Medical Breakthroughs ETF
Proportion
1.99%
ETC 6 Meridian Small Cap Equity ETF
Proportion
1.56%
State Street SPDR S&P Biotech ETF
Proportion
1.44%
Cambria Value and Momentum ETF
Proportion
1.16%
Invesco S&P SmallCap Momentum ETF
Proportion
1%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion
0.94%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion
0.88%